The invention relates to coloured particles with particular mass density, diameters and surface charge comprising pathogen ligands immobilized. The particles are used in methods for detecting and/or characterizing pathogens present in isolated test samples, as well as in methods for detecting and/or characterizing pathogen-binding antibodies present in isolated test samples. A kit comprising the particles is also disclosed.

An implantable diagnostic device in accordance with the present disclosure provides various benefits such as a compact size thereby allowing implanting of the device inside animate objects; low cost due to incorporation of inexpensive detection circuitry and the use of conventional IC fabrication techniques; re-usability by heating thereby allowing multiple diagnostic tests to be performed without discarding the device; and a configuration that allows performing of simultaneous and/or sequential diagnostic tests for detecting one or more similar or dissimilar target molecules concurrently or at different times.

An implantable diagnostic device in accordance with the present disclosure provides various benefits such as a compact size thereby allowing implanting of the device inside animate objects; low cost due to incorporation of inexpensive detection circuitry and the use of conventional IC fabrication techniques; re-usability by heating thereby allowing multiple diagnostic tests to be performed without discarding the device; and a configuration that allows performing of simultaneous and/or sequential diagnostic tests for detecting one or more similar or dissimilar target molecules concurrently or at different times.

There are provided methods for quantifying an analyte in a sample, diagnosing a condition characterized by an excess or a depletion of an analyte in a biological sample, isolating analyte from a sample, and detecting an analyte in a sample. These method comprise the steps of providing a colloidal suspension of nanoparticles of a plasmonic metal, the nanoparticles having attached on their surface a binding moiety for selective attachment of said analyte and adding the sample to the suspension, thus producing a mixture in which said analyte is attached to the nanoparticles in suspension. Then, the methods further comprise the steps of either allowing sedimentation of the nanoparticles with bound analyte, thereby producing a sediment comprising the nanoparticles with bound analyte and a supernatant, and measuring the Localized Surface Plasmon Resonance (LSPR) spectrum of the supernatant and/or recovering the sediment, or measuring the Localized Surface Plasmon Resonance (LSPR) spectrum of the mixture.

There are provided methods for quantifying an analyte in a sample, diagnosing a condition characterized by an excess or a depletion of an analyte in a biological sample, isolating analyte from a sample, and detecting an analyte in a sample. These method comprise the steps of providing a colloidal suspension of nanoparticles of a plasmonic metal, the nanoparticles having attached on their surface a binding moiety for selective attachment of said analyte and adding the sample to the suspension, thus producing a mixture in which said analyte is attached to the nanoparticles in suspension. Then, the methods further comprise the steps of either allowing sedimentation of the nanoparticles with bound analyte, thereby producing a sediment comprising the nanoparticles with bound analyte and a supernatant, and measuring the Localized Surface Plasmon Resonance (LSPR) spectrum of the supernatant and/or recovering the sediment, or measuring the Localized Surface Plasmon Resonance (LSPR) spectrum of the mixture.

Antibody/signal-generating moiety conjugates are disclosed that include an antibody covalently linked to a signal-generating moiety through a heterobifunctional polyalkyleneglycol linker. The disclosed conjugates show exceptional signal-generation in immunohistochemical and in situ hybridization assays on tissue sections and cytology samples. In one embodiment, enzyme-metallographic detection of nucleic acid sequences with hapten-labeled probes can be accomplished using the disclosed conjugates as a primary antibody without amplification.

The methods of the invention employ targeted magnetic particles, preferably targeted nanomagnetic particles, and targeted buoyant particles such as buoyant microparticles and microbubbles. Among the benefits of the invention is the ability to combine targeted magnetic particles with differentially targeted buoyant particles to achieve separation of two or more specifically cell targeted populations during the same work flow.

The methods of the invention employ targeted magnetic particles, preferably targeted nanomagnetic particles, and targeted buoyant particles such as buoyant microparticles and microbubbles. Among the benefits of the invention is the ability to combine targeted magnetic particles with differentially targeted buoyant particles to achieve separation of two or more specifically cell targeted populations during the same work flow.

Disclosed herein are biomarkers associated with a disease state such as lung cancer, and methods of discovering or using said biomarkers. Also disclosed herein are classifiers built on said biomarkers and methods of detecting the disease state in samples from subjects.

The present disclosure provides an improved field effect transistor and device that can be used to sense and characterize a variety of materials. The field effect transistor and/or device including the transistor may be used for a variety of applications, including genome sequencing, protein sequencing, biomolecular sequencing, and detection of ions, molecules, chemicals, biomolecules, metal atoms, polymers, nanoparticles and the like.